Essais liés3clinical trials
VilleNishinomiya-shilocalisation
PaysJapanlocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT03962738

Ouvrir le site du centre

Essais cliniques associés

3
MoléculeIndication / populationPhaseNCTTitreStatut
Lasmiditan Migraine Phase 2 NCT03962738 MONONOFU — A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With Migraine COMPLETED
Rimegepant Migraine Phase 3 NCT05156398 Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects RECRUITING
Rimegepant/BHV3000 Migraine Phase 3 NCT04649242 Randomized Study in Children and Adolescents With Migraine: Acute Treatment RECRUITING